Wilson JM - Search Results

1

Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung.

Fein DE, Limberis MP, Maloney SF, Heath JM, Wilson JM, Diamond SL. Fein DE, et al. Among authors: wilson jm. Mol Ther. 2009 Dec;17(12):2078-87. doi: 10.1038/mt.2009.173. Epub 2009 Jul 28. Mol Ther. 2009. PMID: 19638960 Free PMC article.

2

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Engelhardt JF, Simon RH, Yang Y, Zepeda M, Weber-Pendleton S, Doranz B, Grossman M, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Hum Gene Ther. 1993 Dec;4(6):759-69. doi: 10.1089/hum.1993.4.6-759. Hum Gene Ther. 1993. PMID: 7514445 Free article.

3

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.

Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM. Goldman MJ, et al. Among authors: wilson jm. Hum Gene Ther. 1995 Jul;6(7):839-51. doi: 10.1089/hum.1995.6.7-839. Hum Gene Ther. 1995. PMID: 7578403

4

A recombinant adenoviral vector expressing a soluble form of VCAM-1 inhibits VCAM-1/VLA-4 adhesion in transduced synoviocytes.

Chen SJ, Wilson JM, Vallance DK, Hartman JW, Davidson BL, Roessler BJ. Chen SJ, et al. Among authors: wilson jm. Gene Ther. 1995 Sep;2(7):469-80. Gene Ther. 1995. PMID: 7584125

5

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

Jooss K, Yang Y, Wilson JM. Jooss K, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Aug 20;7(13):1555-66. doi: 10.1089/hum.1996.7.13-1555. Hum Gene Ther. 1996. PMID: 8864756

6

Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Yang Y, et al. Among authors: wilson jm. Gene Ther. 1996 Feb;3(2):137-44. Gene Ther. 1996. PMID: 8867861

7

Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis.

Goldman M, Su Q, Wilson JM. Goldman M, et al. Among authors: wilson jm. Gene Ther. 1996 Sep;3(9):811-8. Gene Ther. 1996. PMID: 8875230

8

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.

Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DB, Greelish JP, Mitchell MA, Wells A, Sweeney HL, Wilson JM. Haecker SE, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Oct 1;7(15):1907-14. doi: 10.1089/hum.1996.7.15-1907. Hum Gene Ther. 1996. PMID: 8894682

9

A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome.

Fisher KJ, Kelley WM, Burda JF, Wilson JM. Fisher KJ, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Nov 10;7(17):2079-87. doi: 10.1089/hum.1996.7.17-2079. Hum Gene Ther. 1996. PMID: 8934222

10

Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.

Zepeda M, Wilson JM. Zepeda M, et al. Among authors: wilson jm. Gene Ther. 1996 Nov;3(11):973-9. Gene Ther. 1996. PMID: 8940637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,867 results

Search Page

Filters